Riskpilot← Back to searchSign inGet full accessDKA CONSULT ApS
APSActiveCVR 15690844Slotsmarken 12, 1. thActivities of holding companies · NACE 6421Est. 19911 employees
Revenue 2024
—
EBITDA margin
—
+32% vs 2023
Equity ratio
-398.3%
Financial strength
Net profit 2024
DKK -16,4M
-61% vs 2023
| Revenue | — | — |
| EBITDA | DKK -47K | +32% |
| Net profit | DKK -16,4M | -61% |
| Total assets | DKK 4,8M | -88% |
| Equity | DKK -19M | -637% |
| Employees | 1 | — |
Legal name
DKA CONSULT ApS
CVR number
15690844
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
1. november 1991
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive handel og industri, herunder at varetage administration af andre selskaber og virksomheder samt at drive investeringsvirksomhed med primær fokus på investering i selskaber indenfor udvikling af lægemidler.
Address
Slotsmarken 12, 1. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.139 | 1.119 | 511 | 18 | 0 | — | — | — | — | 0 | — | — | — |
| Staff expenses | -0 | -1.834 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -4.715 | -3.256 | -8.167 | -125 | -2 | -184 | 61 | -50 | -125 | -311 | -62 | -68 | -47 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -4.715 | -3.256 | -8.167 | -125 | -2 | -184 | 61 | -50 | -125 | -311 | -62 | -68 | -47 |
| Net financials | 85.742 | -257.204 | -1.837 | -76.081 | -5.757 | -4.940 | -1.359 | 6.585 | -1.675 | 8.317 | -13.799 | -10.115 | -16.341 |
| Profit before tax | 81.027 | -260.522 | -10.107 | -76.431 | -5.759 | -5.124 | -1.298 | 6.535 | -1.799 | 8.006 | -13.861 | -10.183 | -16.387 |
| Tax | -196 | -0 | -0 | -0 | -24 | -25 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 81.223 | -260.460 | -10.003 | -76.206 | -5.735 | -5.099 | -1.298 | 6.535 | -1.799 | 8.006 | -13.861 | -10.183 | -16.387 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 413.925 | 146.911 | 128.968 | 54.390 | 50.163 | 47.441 | 47.898 | 56.885 | 57.587 | 61.887 | 51.110 | 39.360 | 4.761 |
| Equity | 368.982 | 107.072 | 97.068 | 20.862 | 15.127 | 10.028 | 8.730 | 15.265 | 13.466 | 21.472 | 7.611 | -2.572 | -18.959 |
| Long-term debt | 10.458 | 4.263 | 4.421 | 931 | 0 | 0 | 0 | 0 | 21.845 | 23.969 | 26.129 | 27.137 | 7.531 |
| Short-term debt | 14.182 | 12.996 | 19.440 | 24.384 | 26.330 | 28.431 | 29.925 | 32.096 | 12.467 | 12.845 | 13.659 | 10.973 | 16.189 |
| Total debt | 24.640 | 17.259 | 23.861 | 25.315 | 26.330 | 28.431 | 29.925 | 32.096 | 34.312 | 36.814 | 39.789 | 38.110 | 23.720 |
EBITDA margin
-4666600.0%
This company
15.8%
Market median
-29535543% vs market
20122024
Equity ratio
-398.3%
This company
38.2%
Market median
-1143% vs market
20122024
Return on equity
-1638733500.0%
This company
18.4%
Market median
-8906160426% vs market
20122024
Net profit margin
-1638733500.0%
This company
8.1%
Market median
-20231277878% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TG Chief Executive Officer | Chief Executive Officer | 2007 | — | — |
TB Management | Management | 2000 | — | — |
ET | Audit | 1991 | — | — |
| Audit | 1991 | — | — | |
MB Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
JH Management | Management | 1991 | — | — |
PE Management | Management | 1991 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1991 | — | — | |
| Board of Directors | 1991 | — | — | |
| Chairman | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DKA CONSULT ApS 
BIOPHARMA HOLDING ApSBoard members of DKA CONSULT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Glæsner Larsen | Chief Executive Officer | 0 companies |
| Torsten Bjørn | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| REVISIONSFIRMAET J. ANDERSEN A/S | Audit | 0 companies |
| Michael Bødker Friis | Chief Executive Officer | 0 companies |
| Jan Herman Larsen | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| John Tyrrestrup | Board of Directors | 0 companies |
| Steen Elverdal | Board of Directors | 0 companies |
| Klaus Henrik Lindblad | Chairman | 0 companies |